Literature DB >> 18982466

Clinical significance of 18F-FDG uptake by primary sites in patients with diffuse large B cell lymphoma in the head and neck: a pilot study.

Byung Hyun Byun1, Im Il Na, Gi Jeong Cheon, Hye Jin Kang, Kyeong Min Kim, Seung-Sook Lee, Baek-Yeol Ryoo, Chang Woon Choi, Sang Moo Lim, Sung Hyun Yang.   

Abstract

OBJECTIVE: This pilot study was launched to explore the utility of positron emission tomography scans, at the time of diagnosis, for clinical outcomes in patients with primary extranodal non-Hodgkin's lymphoma (PENHL) in the head and neck, retrospectively.
METHODS: Twenty-two patients with a diffuse large B cell lymphoma (DLBCL) among those with a PENHL were included. We retrospectively evaluated the clinical outcomes of patients according to the maximum standardized 18F-fluoro-2-deoxy-glucose (18F-FDG) uptake value of the primary lesion (SUVp). The SUVp was initially analyzed as a continuous variable. The cut-off value of SUVp was obtained from receiver-operating characteristic analysis to predict event-free survival. Using this value, patients were divided into those with a low and high SUV.
RESULTS: Seventeen patients (59%) were men and the median age was 50 years. Most primary sites were in Waldeyer's ring (73%). The SUVp ranged from 3.3 to 23.7. The international prognostic index (IPI<2 vs. >or=2) was associated with the SUVp (P=0.014). Patients with low SUVp showed favorable survival (P=0.015). After IPI scores were stratified, the survival difference remained significant (P=0.029).
CONCLUSIONS: The results of this pilot investigation indicate that 18F-FDG uptake of the primary lesion may be related with survival outcomes in patients with extranodal DLBCL in the head and neck. Further studies are needed to confirm and extend these results.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18982466     DOI: 10.1007/s12149-008-0181-9

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  5 in total

1.  18F-FDG PET or PET-CT to evaluate prognosis for head and neck cancer: a meta-analysis.

Authors:  Peng Xie; Minghuan Li; Hanxi Zhao; Xindong Sun; Zheng Fu; Jinming Yu
Journal:  J Cancer Res Clin Oncol       Date:  2011-01-13       Impact factor: 4.553

2.  Evaluating the Predictive Ability of Initial Staging F-18 FDG PET/CT for the Prognosis of Non-Hodgkin Malignant Lymphoma Patients Who Underwent Stem Cell Transplantation.

Authors:  Yun Soo Park; Seok Mo Lee; Ji Sun Park; Sang Kyun Bae; Hye-Kyung Shim; Won-Sik Lee; Sang-Min Lee
Journal:  Nucl Med Mol Imaging       Date:  2017-11-21

3.  Correlation of pretreatment 18F-FDG uptake with clinicopathological factors and prognosis in patients with newly diagnosed diffuse large B-cell lymphoma.

Authors:  Honghui Huang; Fei Xiao; Xiaofeng Han; Lu Zhong; Hua Zhong; Lan Xu; Jianyi Zhu; Beiwen Ni; Jia Liu; Yi Fang; Minyue Zhang; Lijing Shen; Ting Wang; Jianjun Liu; Yiping Shi; Yumei Chen; Luying Zheng; Qiang Liu; Fangyuan Chen; Jianmin Wang
Journal:  Nucl Med Commun       Date:  2016-07       Impact factor: 1.690

4.  Extranodal involvement in lymphoma - A Pictorial Essay and Retrospective Analysis of 281 PET/CT studies.

Authors:  Jayanta Das; Soumendranath Ray; Saugata Sen; Mammen Chandy
Journal:  Asia Ocean J Nucl Med Biol       Date:  2014

5.  Improved Quantification of 18F-FDG PET during 131I-Rituximab Therapy on Mouse Lymphoma Models after 131I Prompt Emission Correction.

Authors:  Young Sub Lee; Hee-Joung Kim; Jin Su Kim
Journal:  Diagnostics (Basel)       Date:  2019-10-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.